Controlled Terminology Best Practices Blog Controlled Terminology Best Practices Simplify Controlled Terminology with expert insights from Sarah Angelo. Overcome challenges, ensure compliance, and improve…Certara2021 年 3 月 3 日
GlobalSubmit WebReview Key Features On-Demand Webinar GlobalSubmit WebReview Key Features Certara2020 年 6 月 22 日
BaseCase Guide to Building Mobile Tools In-house White Paper BaseCase Guide to Building Mobile Tools In-house Certara2020 年 6 月 21 日
FDA’s New ANDA Submissions Guidance: Key Points Blog FDA’s New ANDA Submissions Guidance: Key Points The U.S. Food and Drug Administration (FDA) published notice of a new ANDA submissions guidance…Certara2018 年 9 月 27 日
Achieving Compliance with the FDA’s eCTD Mandate Blog Achieving Compliance with the FDA’s eCTD Mandate The US Food and Drug Administration (FDA) has set 2018 年 5 月 5 日 as the compliance…Certara2018 年 5 月 4 日
FDA’s New Module 1 is a Bridge to eCTD 4 Blog FDA’s New Module 1 is a Bridge to eCTD 4 Editor’s note: Jason Rock served as Project Lead for the HL7 RCRIM Expert Working Group…Certara2016 年 9 月 13 日
Submitting eCTD in Advance of a Milestone Application Blog Submitting eCTD in Advance of a Milestone Application While advanced GPS systems and the advent of Big Data analytics are negating some of…Certara2016 年 5 月 10 日
Best Practices for Placing Drug Master File Reference Letters in Regulatory Applications Blog Best Practices for Placing Drug Master File Reference Letters in Regulatory Applications Within drug applications (ANDA, BLA, IND, or NDA), eCTD (electronic common technical document) Module 3…Certara2016 年 3 月 14 日